17:15 EST Vertex Pharmaceuticals (VRTX) files automatic mixed securities shelf
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRTX:
- Q4 Earnings Surprise Greenlights CRISPR Therapeutics Stock Climb
- Vertex Pharmaceuticals: Strong Financial Performance and Promising Future Prospects Reinforce Buy Rating
- Cautious Outlook on Vertex Pharmaceuticals: Hold Rating Amid Growth Concerns and Premium Valuation
- Vertex Pharmaceuticals upgraded to Hold from Sell at Canaccord yesterday
- Vertex Pharmaceuticals Reports Strong Revenue Growth Amid Challenges